# Suggested Figures Part VI Perplexity.docx

Suggested Figures (Detailed Specifications)

You already proposed 6 figures in VI.7. Here are detailed specifications for each:



Figure VI.1 – Deal Timeline (2015–2025)

Purpose: Show clustering and scale of transactions over time.

Chart type: Bubble chart / timeline

X-axis: Year (2015–2025)

Y-axis: Segment (Pet Brands, Livestock, Omega-3/Upstream, Vet Services)

Bubble size: Deal value (USD millions)

Bubble color: Buyer type (Strategic = blue, PE = orange)

Data points:​



Figure VI.2 – Strategic vs Financial Buyers (by Year)

Purpose: Show deal activity split by buyer type.

Chart type: Stacked bar chart

X-axis: Year (2017–2025)

Y-axis (left): Number of deals

Y-axis (right, optional): Disclosed value ($B)

Stacks: Strategic (blue), Mid-Market PE (orange), Large-Cap PE (green), VC/CVC (grey)

Data (from VI.5.1):​

Strategic: 55% of deals, ~80% of value

Mid-Market PE: 35% of deals, ~15% of value

Large-Cap PE: 5% of deals, ~5% of value

VC/CVC: 5% of deals, minimal value



Figure VI.3 – EV/EBITDA Benchmarks

Purpose: Visualize premium multiples for key deals.

Chart type: Horizontal bar chart or scatter plot

Y-axis: Deal names

X-axis: EV/EBITDA multiple

Data:​

Design notes:

Add horizontal line at 15x as "premium threshold"

Annotate Dechra and NaturVet as outliers



Figure VI.4 – PE Platform Build Example (Gryphon/Vetnique)

Purpose: Show how PE builds platforms via add-ons.

Chart type: Flow diagram / ecosystem map

Structure:

text

[Gryphon Investors]

        |

        ↓

[Vetnique Labs Platform]

    /        \

   ↓          ↓

[US: Stool/Gut]  [UK: Lintbells/YuMOVE]

   |               |

   ↓               ↓

[Heartland Vet Partners] ← Distribution synergy

Annotations:​

Vetnique = US platform (gut health, functional treats)

Lintbells = UK add-on (YuMOVE mobility, 5.5x Inflexion return)

Heartland = Vet clinic roll-up (private-label opportunity)



Figure VI.5 – M&A Heat Map by Subsector

Purpose: Show where deal activity is concentrated.

Chart type: Heat map matrix

X-axis: Years (2017–2025)

Y-axis: Subsectors (Joint/Mobility, Gut/Digestive, Skin/Coat, Enzymes, Phytogenics, Probiotics, Omega-3, Vet Services)

Color intensity: Number of deals (darker = more)

Data (indicative from document):​



Figure VI.6 – 2×2 Valuation Driver Matrix

Purpose: Position key deals on strategic dimensions.

Chart type: 2×2 quadrant matrix

X-axis: Omnichannel / Vet Channel Strength (Low → High)

Y-axis: Clinical Differentiation / Science (Low → High)

Quadrants:

Top-Right: "Premium Valuation" (20x+ EBITDA)

Top-Left: "Science-Led Niche"

Bottom-Right: "Scale Play"

Bottom-Left: "Commodity Risk"

Plot points:​



NEW Figure VI.7 – VC/PE Investor Landscape Map

Purpose: Visual overview of investor positioning.

Chart type: Bubble map or segmented grid

Segments: Early VC (Pet), Early VC (Livestock), Growth VC, Mid-Market PE, Large-Cap PE

Bubbles: Firm names with AUM as size

Data:​



NEW Figure VI.8 – Deal Value by Segment (Pie or Treemap)

Purpose: Show where capital is flowing.

Chart type: Treemap or pie chart

Categories: Pet Nutrition, Pet Supplements, Livestock Feed, Omega-3/Upstream, Vet Pharma/Services

Data (approximate from disclosed deals):​

